NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19

Company Report. Sonnet Biotherapeutics approach may have promise in Covid-19

Princeton based Sonnet Biotherapeutics [NASDAQ:SONN] has an interesting “Trojan Horse” approach that appears to have considerable promise with application in Covid - 19. Sonnet has developed a unique platform that leverages several favorable biological properties of human serum Albumin. They have invented and developed an ingenious approach that converts endogenous albumin into a drug-loaded and/or immune stimulatory Trojan Horse that is taken up by unknowing cancer cells, leading to their destruction". To see the full Report visit the Research Reports tab or this link.

To continue reading, please Login or Join